Researchers from the National Cancer Institute presented their findings at the Society for Nuclear Medicine and Molecular Imaging conference, comparing the use of 18F-DCFPyL PET/CT and multiparametric MRI in detecting biochemical prostate cancer recurrence. The study found that both modalities showed similar cancer detection rates, but the combination of PET/CT and MRI provided superior diagnostic performance. The use of 18F-DCFPyL PET/CT led to an 82.3% cancer detection rate, compared to 80% for multiparametric MRI. The study included 213 patients with biochemical recurrence of prostate cancer, and the authors noted that the combination of PET/CT and MRI outperformed either modality alone.
Thu, 17 Aug 2023 11:28:32 GMT | Diagnostic Imaging